World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
51
Citations
10489
World Ranking
17091
National Ranking
1228

Tomoki Todo publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Tomoki Todo sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 150 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Tomoki Todo D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Tomoki Todo sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 51 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Tomoki Todo is affiliated with the University of Tokyo in Japan and focuses on research within the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Their work frequently covers subfields such as Genetics, Oncology, Molecular Biology, Epidemiology, and Biotechnology.

The scientist's main research topics include:

  • Virus-based gene therapy research
  • CAR-T cell therapy research
  • Herpesvirus Infections and Treatments
  • Glioma Diagnosis and Treatment
  • Cancer Research and Treatments
  • Protein Degradation and Inhibitors
  • Viral Infectious Diseases and Gene Expression in Insects

Published papers of note include:

  • Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial, 2022, Nature Medicine
  • A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma, 2022, Nature Communications
  • Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma, 2022, Molecular Therapy - Oncolytics
  • Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation, 2021, Molecular Therapy - Oncolytics
  • Efficacy of a Third-Generation Oncolytic Herpes Virus G47Δ in Advanced Stage Models of Human Gastric Cancer, 2020, Molecular Therapy - Oncolytics

Frequent co-authors in the scientist's work include:

  • Miwako Iwai
  • Atsushi Hirao
  • Yasushi Ino
  • Kazuya Fukasawa
  • Eiichi Hinoi

Research publications have often appeared in the following venues:

  • Molecular Therapy - Oncolytics (9 publications)
  • Cancer Science (3 publications)
  • Nature Medicine (2 publications)
  • Nature Communications (2 publications)
  • Oncology Letters (2 publications)

Best Publications

  • Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.

    J M Markert;M D Medlock;S D Rabkin;G Y Gillespie

  • Oncolytic virus therapy: A new era of cancer treatment at dawn

    Hiroshi Fukuhara;Yasushi Ino;Tomoki Todo

  • Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors

    Hiroaki Ikushima;Tomoki Todo;Yasushi Ino;Masamichi Takahashi

  • Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.

    Tomoki Todo;Robert L. Martuza;Samuel D. Rabkin;Paul A. Johnson

  • Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation of Intracerebral Injection in Nonhuman Primates

    William D. Hunter;Robert L. Martuza;Frank Feigenbaum;Tomoki Todo

  • Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus.

    Tomoki Todo;Samuel D. Rabkin;Periasamy Sundaresan;Aiguo Wu

  • Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase.

    Tomoki Todo;Masaaki Usui;Kintomo Takakura

  • Functional identification of the primary motor area by corticospinal tractography.

    Kyousuke Kamada;Yutaka Sawamura;Fumiya Takeuchi;Hideaki Kawaguchi

  • Combined use of tractography-integrated functional neuronavigation and direct fiber stimulation

    Kyousuke Kamada;Tomoki Todo;Yoshitaka Masutani;Shigeki Aoki

  • Glioma-initiating Cells Retain Their Tumorigenicity through Integration of the Sox Axis and Oct4 Protein

    Hiroaki Ikushima;Tomoki Todo;Yasushi Ino;Masamichi Takahashi

  • Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma

    Ali Chahlavi;Tomoki Todo;Robert L. Martuza;Samuel D. Rabkin

  • The motor-evoked potential threshold evaluated by tractography and electrical stimulation.

    Kyousuke Kamada;Tomoki Todo;Takahiro Ota;Kenji Ino

  • Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system.

    Hiroshi Fukuhara;Yasushi Ino;Toshihiko Kuroda;Robert L. Martuza

  • 5-Hydroxymethylcytosine Plays a Critical Role in Glioblastomagenesis by Recruiting the CHTOP-Methylosome Complex

    Hiroki Takai;Koji Masuda;Tomohiro Sato;Yuriko Sakaguchi

  • Triple combination of oncolytic herpes simplex virus-1 vectors armed with interleukin-12, interleukin-18, or soluble B7-1 results in enhanced antitumor efficacy.

    Yasushi Ino;Yoshinaga Saeki;Hiroshi Fukuhara;Tomoki Todo

  • Oncolytic virus therapy using genetically engineered herpes simplex viruses.

    Tomoki Todo

  • Visualization of the frontotemporal language fibers by tractography combined with functional magnetic resonance imaging and magnetoencephalography.

    Kyousuke Kamada;Tomoki Todo;Yoshitaka Masutani;Shigeki Aoki

  • Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice.

    A Chahlavi;S D Rabkin;T Todo;P Sundaresan

  • Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus.

    Tomoki Todo;Frank Feigenbaum;Samuel D. Rabkin;Fred Lakeman

  • Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone.

    Masaaki Usui;Nobuhito Saito;Katsumi Hoya;Tomoki Todo

Frequent Co-Authors

Samuel D. Rabkin
Samuel D. Rabkin Harvard University
Robert L. Martuza
Robert L. Martuza Harvard Medical School
Kohei Miyazono
Kohei Miyazono University of Tokyo
Atsushi Hirao
Atsushi Hirao Kanazawa University
Tetsu Akiyama
Tetsu Akiyama University of Tokyo
Hideo Iba
Hideo Iba Chiba University
Hiroyuki Aburatani
Hiroyuki Aburatani University of Tokyo
Takaaki Kirino
Takaaki Kirino University of Tokyo
Keiji Miyazawa
Keiji Miyazawa University of Yamanashi
Atsushi Natsume
Atsushi Natsume Nagoya University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a biology or biochemistry focus in the USA, a variety of online degrees can expand your career options in the healthcare and life sciences field. Many students branch into specialized areas, such as psychiatric care. For example, psych np programs offer a pathway for those interested in mental health nursing, combining biology knowledge with advanced practice skills.

Nutrition is another area closely tied to biochemistry. Accelerated programs, like a 2 year nutrition degree online, allow you to specialize in human nutrition and health quickly and flexibly.

For those interested in management or administrative roles, pursuing the cheapest online mba in healthcare management can prepare you for leadership positions within hospitals, biotech companies, or research organizations.

Additionally, knowledge of biology can support technical careers such as coding and billing in healthcare. Earning a certified coding specialist (ccs) credential can open doors to well-paid roles in medical records and health information management.

Best Scientists Citing Tomoki Todo

Trending Scientists

Recently Published Articles